versión imprimible

Liquid Biopsy Surveillance and Early Detection Summit

Evvnt Promotion / evvnt
16.11.2022 - 17.11.2022  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 07:30 - 16:00
Temas de la conferencia
In the wake of new FDA guidance and exciting MRD partnership announcements between Grail and AstraZeneca, Amgen and Bristol Myers Squibb the liquid biopsy industry is experiencing a paradigm shift. Touted as having the potential to transform clinical practice as we know it, technical progress and mounting investment in premetastatic applications are creating huge industry-wide excitement for liquid biopsy-based screening and surveillance for novel precision drug development.
Organizador profesional (PCO)
Hanson Wade

Speakers: Aadel Chaudhuri, Assistant Professor of Radiation Oncology, Washington University School of Medicine, and more.

Información e inscripción:
Mr. Alex Domingo
Medicina General
Cuota del Congreso
Drug Developers and Academics Conference Pass: USD 0.50, Commercial Vendors Conference Pass: USD 3599.00, Technical Vendors Conference Pass: USD 2599.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÖsterreichische Gesellschaft für Public HealthÖsterreichisches Rotes KreuzAMREF - African Medical and Research FoundationHelix - Forschung & Beratung WiennewTreeCenter of ExcellenceEuropean Health Forum Gastein